person

Barbro L.

Country
Sweden
Department
Onkologiska kliniken

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
102
Sites with multiple studies

Has run more than one trial at 102 of 316 partner sites.

Specializations

Breast Cancer Subtypes

This investigator specializes in various forms of breast cancer, with particular emphasis on HER2-positive breast cancer and triple-negative breast cancer. Their research encompasses both early-stage and advanced disease states.

  • HER2-positive breast cancer management
  • Triple-negative breast cancer treatment
  • Hormone receptor-positive breast cancer

The investigator focuses on molecular classification and targeted therapeutic approaches for different breast cancer subtypes.

Therapeutic Innovation

The researcher explores novel therapeutic strategies including targeted therapies and neoadjuvant treatments. Their work involves investigating innovative drug combinations and treatment sequences.

  • Antibody-drug conjugates
  • PARP inhibitors
  • Endocrine therapy optimization

Their research includes evaluation of treatment responses and pathological complete remission rates.

Specialized Areas

The investigator's expertise extends to fertility preservation in cancer patients and genetic aspects of breast cancer treatment.

  • BRCA-mutated breast cancer
  • Ovarian function preservation
  • Long-term endocrine therapy

Their work includes assessment of treatment effects on reproductive health and genetic-based therapeutic selection.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.